Cargando…
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer
To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients with SVI, which is known as a factor of very high...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602636/ https://www.ncbi.nlm.nih.gov/pubmed/34795362 http://dx.doi.org/10.1038/s41598-021-01900-4 |
_version_ | 1784601613171687424 |
---|---|
author | Yanai, Yoshinori Kosaka, Takeo Mikami, Shuji Hongo, Hiroshi Yasumizu, Yota Takeda, Toshikazu Matsumoto, Kazuhiro Miyauchi, Jun Kitano, Shigehisa Oya, Mototsugu |
author_facet | Yanai, Yoshinori Kosaka, Takeo Mikami, Shuji Hongo, Hiroshi Yasumizu, Yota Takeda, Toshikazu Matsumoto, Kazuhiro Miyauchi, Jun Kitano, Shigehisa Oya, Mototsugu |
author_sort | Yanai, Yoshinori |
collection | PubMed |
description | To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients with SVI, which is known as a factor of very high-risk PCa. Preoperative clinical variables and postoperative pathological variables were evaluated as predictors of biochemical recurrence (BCR) with a multivariate logistic regression. Immune cell infiltration including the CD8-positive cell (CD8(+) cell) and CD204-positive M2-like macrophage (CD204(+) cell) was investigated by immunohistochemistry. The cumulative incidence and risk of BCR were assessed with a Kaplan–Meier analysis and competing risks regression. A higher CD8(+) cell count in the SVI area significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). A lower CD204(+) cell count in the SVI area also significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). Furthermore, the combination of the CD8(+) and CD204(+) cell infiltration ratio of the SVI area to the main tumor area was a significant factor for BCR in the patients with the PCa with SVI (p = 0.001). In PCa patients with SVI, the combination of CD8(+) and CD204(+) cell infiltration is useful to predict the prognosis. |
format | Online Article Text |
id | pubmed-8602636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86026362021-11-22 CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer Yanai, Yoshinori Kosaka, Takeo Mikami, Shuji Hongo, Hiroshi Yasumizu, Yota Takeda, Toshikazu Matsumoto, Kazuhiro Miyauchi, Jun Kitano, Shigehisa Oya, Mototsugu Sci Rep Article To stratify the heterogeneity of prostate cancer (PCa) with seminal vesicle invasion (SVI) immunologically after radical prostatectomy focusing on the tumor microenvironment. We retrospectively reviewed the clinicopathological data of 71 PCa patients with SVI, which is known as a factor of very high-risk PCa. Preoperative clinical variables and postoperative pathological variables were evaluated as predictors of biochemical recurrence (BCR) with a multivariate logistic regression. Immune cell infiltration including the CD8-positive cell (CD8(+) cell) and CD204-positive M2-like macrophage (CD204(+) cell) was investigated by immunohistochemistry. The cumulative incidence and risk of BCR were assessed with a Kaplan–Meier analysis and competing risks regression. A higher CD8(+) cell count in the SVI area significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). A lower CD204(+) cell count in the SVI area also significantly indicated a favorable prognosis for cancers with SVI (p = 0.004). Furthermore, the combination of the CD8(+) and CD204(+) cell infiltration ratio of the SVI area to the main tumor area was a significant factor for BCR in the patients with the PCa with SVI (p = 0.001). In PCa patients with SVI, the combination of CD8(+) and CD204(+) cell infiltration is useful to predict the prognosis. Nature Publishing Group UK 2021-11-18 /pmc/articles/PMC8602636/ /pubmed/34795362 http://dx.doi.org/10.1038/s41598-021-01900-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Yanai, Yoshinori Kosaka, Takeo Mikami, Shuji Hongo, Hiroshi Yasumizu, Yota Takeda, Toshikazu Matsumoto, Kazuhiro Miyauchi, Jun Kitano, Shigehisa Oya, Mototsugu CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title | CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title_full | CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title_fullStr | CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title_full_unstemmed | CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title_short | CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
title_sort | cd8-positive t cells and cd204-positive m2-like macrophages predict postoperative prognosis of very high-risk prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602636/ https://www.ncbi.nlm.nih.gov/pubmed/34795362 http://dx.doi.org/10.1038/s41598-021-01900-4 |
work_keys_str_mv | AT yanaiyoshinori cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT kosakatakeo cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT mikamishuji cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT hongohiroshi cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT yasumizuyota cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT takedatoshikazu cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT matsumotokazuhiro cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT miyauchijun cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT kitanoshigehisa cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer AT oyamototsugu cd8positivetcellsandcd204positivem2likemacrophagespredictpostoperativeprognosisofveryhighriskprostatecancer |